Old Articles: <Older 4051-4060 Newer> |
|
Pharmaceutical Executive July 1, 2012 |
Country Report: Thailand Indochina's biggest pharmaceutical market has quickly matured over the past years due to the implementation of heavy cost containment measures meant to make healthcare more accessible to the patient. |
Fast Company Jul/Aug 2012 April Rabkin |
How The Failed Aakash Tablet Is An Object Lesson In India's Long Road Ahead To Tech Innovation For all its success at churning out engineers by the hundreds of thousands and sending Silicon Valley countless gifted computer scientists, India has never been much good at producing hardware. |
IEEE Spectrum June 2012 Peter Fairley |
Cleaner Coal's Last Stand China's first coal-gasification power plant starts operating amid high hopes, delays, and cost overruns |
Fast Company May 2012 Rachel Z. Arndt |
Georgia Chopsticks Finds A New Market In China Jae Lee, founder and owner of Georgia Chopsticks shows that it's not always what you make that counts as innovation but how you make it and whom you sell it to. |
Fast Company May 2012 Lindsey Kratochwill |
A South Korean Augmented-Reality Theme Park Puts Disneyland To Shame In the 1960s, Disneyland wowed visitors with audio-animatronics -- and American theme parks have seen few innovations since. That may change, if the Korean export Live Park successfully breaks in. |
IndustryWeek April 18, 2012 |
Rare Earths, Major Headache The race for rare earths is on as China's dominance of the critical minerals sets off a wave of supply chain concerns. |
Pharmaceutical Executive April 1, 2012 |
Leading from the South India's most prominent scientist sets a new agenda for pharma in emerging markets. |
IEEE Spectrum April 2012 Yu-Tzu Chiu |
Taiwan's Tech Hubs Take Advantage of Disasters After Japan's earthquake and Thailand's floods, firms are building backup manufacturing sites |
Chemistry World March 20, 2012 Rajesh Parishwad |
India Green Lights Production of Patented Cancer Drug For the first time India has invoked a 'compulsory license' clause to cut the cost of a patented anti-cancer drug by allowing another company to manufacture the therapy. |
Registered Rep. March 16, 2012 John Aidan Byrne |
UBS Betting Big On Asia UBS Wealth Management will embark on a global expansion outside the U.S., announcing yesterday it will hire another 500 advisers in the fast-growing emerging markets and Asia Pacific regions. |
<Older 4051-4060 Newer> Return to current articles. |